How HLS’s Platform Works
Our dual-acting anti-infectives kill bacteria by preventing their interaction with nutrient accumulation. This results through effects of bacterial two-component systems, blocking gene function. The bacteria die in minutes. The chance of developing resistance to our anti-infectives is approximately 1 chance in 10 followed by 104 zeros, thus extremely unlikely.
Below is Patrick Schlievert, PhD–Founder and Board Member demonstrating one of the dual-acting anti-infectives as a clear gel that can be used on skin and mucosal surfaces to kill bacterial and prevent inflammation.